FCL Fineotex Chemical Q4 FY26 results (Jan–Mar 2026) and concall
Fineotex Chemical Limited reported a strong Q4 FY26, with significant revenue and PAT growth, largely propelled by the successful integration and performance of the CrudeChem acquisition. The company is actively expanding CrudeChem's capacity and targeting substantial revenue growth from this segment, while also seeing robust performance in its core textile chemicals business. Management is focused on operational efficiencies and aims for higher blended EBITDA margins in the near future.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue down 9.3%, net profit up 10.5% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 115 | 109 | 108 | 98 | 105 −9% | 96 −12% | 98 −9% |
| EBITDA | 30 | 30 | 20 | 17 | 23 −23% | 22 −27% | 19 −5% |
| Net profit | 31 | 24 | 19 | 20 | 25 −19% | 26 +8% | 21 +11% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





